
Sign up to save your podcasts
Or


Can a single bolus change the fate of a devastating stroke? ๐ง ๐
The TRACE-5 trial (Lancet 2026) shows that tenecteplase within 24 h for basilar artery occlusion improves excellent functional outcomes (38% vs 29%; RR 1.50, p=0.014) without increased haemorrhage or mortality. ๐
Pragmatic design. No mandatory advanced imaging. Feasible globally. ๐
If confirmed beyond Asian cohorts, this could reshape late-window stroke care.
Single shot. Shifted scale. Strong signal. ๐๐
By Dr RR Baliga, MD, MBA5
66 ratings
Can a single bolus change the fate of a devastating stroke? ๐ง ๐
The TRACE-5 trial (Lancet 2026) shows that tenecteplase within 24 h for basilar artery occlusion improves excellent functional outcomes (38% vs 29%; RR 1.50, p=0.014) without increased haemorrhage or mortality. ๐
Pragmatic design. No mandatory advanced imaging. Feasible globally. ๐
If confirmed beyond Asian cohorts, this could reshape late-window stroke care.
Single shot. Shifted scale. Strong signal. ๐๐

907 Listeners

3,377 Listeners

20,663 Listeners